Breast Cancer Immunotherapy Update
February 27, 2018
What are the newest updates in breast cancer with immunotherapy? Most of the current research is around triple negative breast cancer and individuals who have a BRCA1 or BRCA2 genetic mutation. Join Melinda Telli, MD, Assistant Professor of Medicine (Oncology) Stanford University Medical Center as she discusses these updates.
This webinar has advanced and technical content.
People concerned about hereditary cancer, cancer survivors, previvors, and health care providers.